K Number
K183173
Manufacturer
Date Cleared
2019-07-01

(227 days)

Product Code
Regulation Number
892.1560
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

LIGHTMED Ultrasound System is a non-invasion diagnostic ophthalmic ultrasound instrument specifically designed for measurements inside the ocular structures including orbital, anterior, posterior segment of eye and axial length for determination of IOL Power.

Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: Ophthalmic

Device Description

The LIGHTMED Ultrasound System (model name: LIGHTSonic Ultrasound) is a portable ultrasound biometric ruler intended for use in ophthalmic applications. The system allows for the measurement of several key ocular features including axial length (AXL), anterior chamber depth. The device is used by coupling the probe / transducer to the eye either through direct contact or immersion methods. Available modes are A scan, biometric B-scan and UBM.

The A-scan mode of the system features a live A scan trace with storage for up to four scans. There are four (auto/manual) examination modes that use 9 different tissue velocities to calculate individual intraocular distances within the eye (AXL, ACD, Lens, and Vitreous). Other features include: post examination review of scans & measurement; four IOL formulas for lens power calculations; an immersion scanning capability for zero corneal compression of the eye while scanning and storage for up to five different user files.

The B-Scan mode produces a live, two-dimensional image to facilitate the identification and measurement of ocular pathologies in the posterior-chamber of the eye, particularly when view of the chamber is obscured, such as is the case with cataracts.

The UBM mode can be used with a 35 MHz or a 50 MHz transducer. Because of the higher frequency of the transducer, it is expected that its greatest field of application will be in visualizing the anterior segment, because the focus area is about 11 mm from the transducer plane. The system will visualize other parts of the resolution is not as high. LIGHTMED Ultrasound System is a stand-alone system that runs on a Windows 10 platform and may be networked (by the user) for interface with electronic medical records systems, printing, and other purposes. The system consists of the console, ultrasound probe(s) and transducer, and foot pedal.

AI/ML Overview

This document is a FDA 510(k) premarket notification clearance letter for the LIGHTMED Ultrasound System. It describes the device, its intended use, and demonstrates its substantial equivalence to previously cleared predicate devices.

However, this document does NOT contain a study that proves the device meets specific acceptance criteria based on AI or algorithm performance. The performance data provided are related to:

  • Biocompatibility testing: Ensuring the patient contact materials are safe.
  • Electrical safety and electromagnetic compatibility (EMC): Compliance with safety standards.
  • Software verification and validation testing: Ensuring the software operates correctly and safely.
  • Measurement accuracy: A general statement that the system "has been validated and is safe and effective for the intended use" without providing specific accuracy metrics or the study details behind this validation.

There is no mention of an AI component, an algorithm-only (standalone) performance study, a multi-reader multi-case (MRMC) comparative effectiveness study, or detailed acceptance criteria for diagnostic accuracy metrics (e.g., sensitivity, specificity, AUC). The device is described as an "ultrasound biometric ruler" and "a non-invasion diagnostic ophthalmic ultrasound instrument," implying it performs measurements and imaging, but not an AI-driven interpretation or detection system.

Therefore, I cannot provide the requested information regarding acceptance criteria and the study that proves the device meets those criteria for an AI/algorithm-driven system, as these details are not present in the provided text.

Based on the provided text, the device is an ultrasound system with A-scan, B-scan, and UBM modes, primarily used for measurements and imaging of ocular structures. Its clearance is based on demonstrating substantial equivalence to existing ultrasound devices and meeting general safety and performance standards for such medical devices.

{0}------------------------------------------------

July 1, 2019

Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health and Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, with the word "ADMINISTRATION" underneath.

Lightmed USA, Inc. % Hedy Chiang Regulatory Affairs Administrator 1130 Calle Cordillera SAN CLEMENTE CA 92673

Re: K183173

Trade/Device Name: LIGHTMED Ultrasound System Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasonic pulsed echo imaging system Regulatory Class: Class II Product Code: IYO, ITX Dated: June 4, 2019 Received: June 5, 2019

Dear Hedy Chiang:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmp/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see

{1}------------------------------------------------

https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

For

Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration

Indications for Use

Form Approved: OMB No. 0910-0120 Expiration Date: 06/30/2020 See PRA Statement below.

510(k) Number (if known) K183173

Device Name LIGHTMED Ultrasound System

Indications for Use (Describe)

LIGHTMED Ultrasound System is a non-invasion diagnostic ophthalmic ultrasound instrument specifically designed for measurements inside the ocular structures including orbital, anterior, posterior segment of eye and axial length for determination of IOL Power.

Type of Use (Select one or both, as applicable)
-------------------------------------------------

X Prescription Use (Part 21 CFR 801 Subpart D)

_ Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

FORM FDA 3881 (7/17)

Page 1 of 1
6-1

PSC Publishing Services (301) 443-6740 EF

{3}------------------------------------------------

LIGHTMED Ultrasound System System:_______________________________________________________________________________________________________________________________________________________________________

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical ApplicationMode of Operation
GeneralSpecificBMPWDCWDColorCombinedOther*
(Track 1 Only)(Tracks 1 & 3)Doppler(Specify)(Specify)
OphthalmicOphthalmicP(A- mode)
N
Fetal ImagingFetal
& OtherAbdominal
Intra-operative (Specify)
Intra-operative (Neuro)
Laparoscopic
Pediatric
Small Organ (Specify)
Neonatal Cephalic
Adult Cephalic
Trans-rectal
Trans-vaginal
Trans-urethral
Trans-esoph. (non-
Card.)
Musculo-skeletal
(Conventional)
Musculo-skeletal
(Superficial)
Intravascular
CardiacCardiac Adult
Cardiac Pediatric
Intravascular (Cardiac)
Trans-esoph. (Cardiac)
Intra-cardiac
Other (Specify)
PeripheralPeripheral vessel
VesselOther (Specify)

N = new indication; P = previously cleared in K170761

$\frac{}{\text{Signature}}$

6-2

{4}------------------------------------------------

System:_______________________________________________________________________________________________________________________________________________________________________

Transducer:

Transducer:___________________________________________________________________________________________________________________________________________________________________

Probe

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical ApplicationMode of Operation
General(Track 1Only)Specific(Tracks 1 & 3)BMPWDCWDColorDopplerCombined(Specify)Other*(Specify)
OphthalmicOphthalmic(A- mode)N
FetalImaging &OtherFetalAbdominal
Intra-operative (Specify)
Intra-operative (Neuro)
Laparoscopic
Pediatric
Small Organ (Specify)
Neonatal Cephalic
Adult Cephalic
Trans-rectal
Trans-vaginal
Trans-urethral
Trans-esoph. (non-Card.)
Musculo-skeletal(Conventional)
Musculo-skeletal(Superficial)
Intravascular
CardiacCardiac Adult
Cardiac Pediatric
Intravascular (Cardiac)
Trans-esoph. (Cardiac)
Intra-cardiac
Other (Specify)
PeripheralVesselPeripheral vessel
Other (Specify)

6-3

{5}------------------------------------------------

N = new indication; P = previously cleared in K170761

System: _ ____________________________________________________________________________________________________________________________________________________________________ Transducer:_______12MHz, 20MHz B-scan Probe

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical ApplicationMode of Operation
General(Track 1Only)Specific(Tracks 1 & 3)BMPWDCWDColorDopplerCombined(Specify)Other*(Specify)
OphthalmicOphthalmicP
FetalImaging &OtherFetal
Abdominal
Intra-operative (Specify)
Intra-operative (Neuro)
Laparoscopic
Pediatric
Small Organ (Specify)
Neonatal Cephalic
Adult Cephalic
Trans-rectal
Trans-vaginal
Trans-urethral
Trans-esoph. (non-Card.)
Musculo-skeletal(Conventional)
Musculo-skeletal(Superficial)
Intravascular
CardiacCardiac Adult
Cardiac Pediatric
Intravascular (Cardiac)
Trans-esoph. (Cardiac)
Intra-cardiac
Other (Specify)
PeripheralVesselPeripheral vessel
Other (Specify)

$\frac{1}{6-4}$

{6}------------------------------------------------

N = new indication; P = previously cleared in K170761

System: LIGHTMED Ultrasound System

Transducer:_35MHz, 50MHz UBM Probe

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical ApplicationMode of Operation
SpecificBMPWDCWDColorDopplerCombined(Specify)Other*(Specify)
General(Track 1Only)(Tracks 1 & 3)
OphthalmicOphthalmicP
Imaging &OtherFetal
Abdominal
Intra-operative (Specify)
Intra-operative (Neuro)
Laparoscopic
Pediatric
Small Organ (Specify)
Neonatal Cephalic
Adult Cephalic
Trans-rectal
Trans-vaginal
Trans-urethral
Trans-esoph. (non-Card.)
Musculo-skeletal(Conventional)
Musculo-skeletal(Superficial)
CardiacIntravascular
Cardiac Adult
Cardiac Pediatric
Intravascular (Cardiac)
Trans-esoph. (Cardiac)
Intra-cardiac
Other (Specify)
PeripheralVesselPeripheral vessel
Other (Specify)

N = new indication; P = previously cleared in K170761

5-6
6-5

{7}------------------------------------------------

Section 7 510(k) Summary

I. SUBMITTER

K183173

LIGHTMED USA, INC. 1130 Calle Cordillera, San Clemente, CA 92673, U.S.A. T: +1-949-218-9555 F: +1-949-218-9556 Contact Person: Hedy Chiang/Regulatory Affairs Coordinator Date Prepared: Oct 26, 2018

II. DEVICE

Trade name: LIGHTMED Ultrasound System Model name: LIGHTSonic Ultrasound Classification name: System, Imaging, Pulsed Echo, Ultrasonic Classification Panel: Radiology Regulation number: 892.1560, 892.1570 Product code: IYO, ITX

III. PREDICATE DEVICE

Substantial equivalence to the following predicate device is as follows:

Primary Predicate DeviceLIGHTMED USA, INCLIGHTSonic B UBMK170761DecisionDate:04/13/2018
Reference DeviceSonomed Inc. VupadK140199DecisionDate:04/01/2014

IV. DEVICE DESCRIPTION

The LIGHTMED Ultrasound System (model name: LIGHTSonic Ultrasound) is a portable ultrasound biometric ruler intended for use in ophthalmic applications. The system allows for the measurement of several key ocular features including axial length (AXL), anterior chamber depth. The device is used by coupling the probe / transducer to the eye either through direct contact or immersion methods. Available modes are A scan, biometric B-scan and UBM.

{8}------------------------------------------------

The A-scan mode of the system features a live A scan trace with storage for up to four scans. There are four (auto/manual) examination modes that use 9 different tissue velocities to calculate individual intraocular distances within the eye (AXL, ACD, Lens, and Vitreous). Other features include: post examination review of scans & measurement; four IOL formulas for lens power calculations; an immersion scanning capability for zero corneal compression of the eye while scanning and storage for up to five different user files.

The B-Scan mode produces a live, two-dimensional image to facilitate the identification and measurement of ocular pathologies in the posterior-chamber of the eye, particularly when view of the chamber is obscured, such as is the case with cataracts.

The UBM mode can be used with a 35 MHz or a 50 MHz transducer. Because of the higher frequency of the transducer, it is expected that its greatest field of application will be in visualizing the anterior segment, because the focus area is about 11 mm from the transducer plane. The system will visualize other parts of the resolution is not as high. LIGHTMED Ultrasound System is a stand-alone system that runs on a Windows 10 platform and may be networked (by the user) for interface with electronic medical records systems, printing, and other purposes. The system consists of the console, ultrasound probe(s) and transducer, and foot pedal.

V. INDICATIONS FOR USE

LIGHTMED Ultrasound System is a non-invasion diagnostic ophthalmic ultrasound instrument specifically designed for measurements inside the ocular structures including orbital, anterior, posterior segment of eye and axial length for determination of IOL Power.

{9}------------------------------------------------

System: _

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical ApplicationMode of Operation
General(Track 1 Only)Specific(Tracks 1 & 3)BMPWDCWDColorDopplerCombined(Specify)Other*(Specify)
OphthalmicOphthalmicP(A- mode)N
Fetal Imaging& OtherFetal
Abdominal
Intra-operative (Specify)
Intra-operative (Neuro)
Laparoscopic
Pediatric
Small Organ (Specify)
Neonatal Cephalic
Adult Cephalic
Trans-rectal
Trans-vaginal
Trans-urethral
Trans-esoph. (non-Card.)
Musculo-skeletal(Conventional)
Musculo-skeletal(Superficial)
Intravascular
CardiacCardiac Adult
Cardiac Pediatric
Intravascular (Cardiac)
Trans-esoph. (Cardiac)
Intra-cardiac
Other (Specify)
PeripheralVesselPeripheral vessel
Other (Specify)

N = new indication; P = previously cleared in K170761

{10}------------------------------------------------

LIGHTMED Ultrasound System Transducer:_____10MHz A-scan Probe System:

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

Clinical ApplicationMode of Operation
General(Track 1Only)Specific(Tracks 1 & 3)BMPWDCWDColorDopplerCombined(Specify)Other*(Specify)
OphthalmicOphthalmic(A- mode)N
FetalImaging &OtherFetal
Abdominal
Intra-operative (Specify)
Intra-operative (Neuro)
Laparoscopic
Pediatric
Small Organ (Specify)
Neonatal Cephalic
Adult Cephalic
Trans-rectal
Trans-vaginal
Trans-urethral
Trans-esoph. (non-Card.)
Musculo-skeletal(Conventional)
Musculo-skeletal(Superficial)
Intravascular
CardiacCardiac Adult
Cardiac Pediatric
Intravascular (Cardiac)
Trans-esoph. (Cardiac)
Intra-cardiac
Other (Specify)
PeripheralVesselPeripheral vessel
Other (Specify)

N = new indication; P = previously cleared in K170761

{11}------------------------------------------------

System:LIGHTMED Ultrasound System_________________________________________________________________________________________________________________________

Transducer:_____12MHz, 20MHz B-scan

Probe_____

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Clinical ApplicationMode of Operation
General(Track 1Only)Specific(Tracks 1 & 3)BMPWDCWDColorDopplerCombined(Specify)Other*(Specify)
OphthalmicOphthalmicP
FetalImaging &OtherFetal
Abdominal
Intra-operative (Specify)
Intra-operative (Neuro)
Laparoscopic
Pediatric
Small Organ (Specify)
Neonatal Cephalic
Adult Cephalic
Trans-rectal
Trans-vaginal
Trans-urethral
Trans-esoph. (non-Card.)
Musculo-skeletal(Conventional)
Musculo-skeletal(Superficial)
Intravascular
CardiacCardiac Adult
Cardiac Pediatric
Intravascular (Cardiac)
Trans-esoph. (Cardiac)
Intra-cardiac
Other (Specify)
PeripheralVesselPeripheral vessel
Other (Specify)
Clinical ApplicationMode of Operation
General(Track 1Only)Specific(Tracks 1 & 3)BMPWDCWDColorDopplerCombined(Specify)Other*(Specify)
OphthalmicOphthalmicP
FetalImaging &OtherFetal
Abdominal
Intra-operative (Specify)
Intra-operative (Neuro)
Laparoscopic
Pediatric
Small Organ (Specify)
Neonatal Cephalic
Adult Cephalic
Trans-rectal
Trans-vaginal
Trans-urethral
Trans-esoph. (non-Card.)
Musculo-skeletal(Conventional)
Musculo-skeletal(Superficial)
Intravascular
Cardiac Adult
CardiacCardiac Pediatric
Intravascular (Cardiac)
Trans-esoph. (Cardiac)
Intra-cardiac
Other (Specify)
Peripheral vessel
PeripheralVesselOther (Specify)

N = new indication; P = previously cleared in K170761

{12}------------------------------------------------

LIGHTMED Ultrasound System Transducer: 35MHz, 50MHz UBM Probe System:

Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:

N = new indication; P = previously cleared in K170761

{13}------------------------------------------------

VI. COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE PREDICATE DEVICE

A summary of the LIGHTMED Ultrasound System design characteristics that are identical as the predicate is provided below:

Product nameLIGHTMED UltrasoundSystemLIGHTMED UltrasoundSystemVuPad
Model nameLIGHTSonic UltrasoundLIGHTSonic B UBMVuPad
ManufacturerLIGHTMED USA, INC.LIGHTMED USA, INC.Sonomed Inc.
510(k) numberK170761K140199
Intended use* visualize the interior ofthe eye* make measurementinside the eye such as- axial length- anterior chamber depth- lens thickness* make measurementsinside the ocular structuresincluding- orbital structure- anterior segment of eye- posterior segment of eye* visualize the interior ofthe eye* make measurementinside the eye such as- axial length- anterior chamber depth- lens thickness
Hard drive128 GB C-fast card128 GB C-fast card128 GB SSD solid-statedrive
Operatingvoltage100 - 240 VAC, 50/60Hz auto-switchingmedical-grade powersupply100 - 240 VAC, 50/60 Hzauto-switching medical-grade power supply100 - 240 VAC, 50/60Hz auto-switchingmedical-grade powersupply
ControlinterfaceOperator uses LCDmulti-touch control paneland foot pedal switch tocollect exam data.Operator uses LCD multi-touch control panel andfoot pedal switch to collectexam data.Operator uses LCDmulti-touch control paneland foot pedal switch tocollect exam data.
EMRDICOMDICOMDICOM
Generalmethod ofoperation* Echoes converted toimages on a screen* Measurement made bytime delays* Echoes converted toimages on a screen* Measurement made bytime delays* Echoes converted toimages on a screen* Measurement made bytime delays
Digital systemEchoes converted intodigital pulses, alloperation carried outdigitally.Echoes converted intodigital pulses, all operationcarried out digitally.Echoes converted intodigital pulses, alloperation carried outdigitally.
Probe design* A-scan: closed fixedsingle-element withinternal fixation light* B-scan: sealed probeswith focusedtransducer* UBM: water pathprobe withinterchangeablefocused transducerB-scan: sealed probeswith focused transducer* UBM: water path probewith interchangeablefocused transducer* A-scan: closed fixedsingle-element withinternal fixation light* B-scan: sealed probeswith focusedtransducer* UBM: water path probewith interchangeablefocused transducer
Pulse repetitionfrequencyA-scan: 5880 HzB-scan & UBM: 2560HzB-scan & UBM: 2560 HzA-scan: 5880 HzB-scan & UBM: 2560 Hz
Export imagePDF ; JPEG; AVIPDF ; JPEG; AVIPDF ; JPEG; AVI
PrinterAny Windows-compatibleprinter (separate)Any Windows-compatibleprinter (separate)Any Windows-compatible printer(separate)

{14}------------------------------------------------

A summary of the LIGHTMED Ultrasound System design characteristics differ from the predicate is provided below:

Product nameLIGHTMED UltrasoundSystemLIGHTMED UltrasoundSystemVuPad
Model nameLIGHTSonic UltrasoundLIGHTSonic B UBMVuPad

{15}------------------------------------------------

ManufacturerLIGHTMED USA, INC.LIGHTMED USA, INC.Sonomed Inc.
510(k) numbernewK170761K140199
Unit12.75" w x 3" d x 8" h(32.3 x 7.6 x 20.3 cm)12.75" w x 3" d x 8" h(32.3 x 7.6 x 20.3 cm)13.3" w x 8.0" d x 2" h
Device systemThe LIGHTSonicUltrasound is an advancedmicroprocessor-controlledultrasonic system,composed of the followingsub-systems:* LCD control panelA mode probe B-scan probes* UBM probes* foot pedal switchThe LIGHTSonicUltrasound is an advancedmicroprocessor-controlledultrasonic system,composed of the followingsub-systems:* LCD control panel* B-scan probes* UBM probes* foot pedal switchVupad is an innovativeultrasonic system,composed of the followingsub-systems:* LCD touch screen* sealed A-probe* B-probes* UBM probes* foot pedal
OperatingsystemMicrosoft Windows 10Microsoft Windows 10Microsoft Windows 8
Annotationimage annotation with sixtools: orientation, angle,distance, pointer, area, textimage annotation with sixtools: orientation, angle,distance, pointer, area, textautomatic annotation ofimages and video clips
Scan controlsfully adjustable time gaincontrol (TGC)fully adjustable time gaincontrol (TGC)fully adjustable time-variedgain (TVG), baseline, loggain, and exponential gain(e-gain)
Compliancestandard* US Federal PerformanceStandards 21 CFR892.1560 for Class IIUltrasonic products- AAMI/ANSI ES60601-1:2005/(R)2012 andA1:2012,C1:2009/(R)2012 and* US Federal PerformanceStandards 21 CFR892.1560 for Class IIUltrasonic products- AAMI/ANSI ES60601-1:2005/(R)2012 andA1:2012,C1:2009/(R)2012 and* US Federal PerformanceStandards 21 CFR892.1560 and 1570 forClass II Ultrasonicproducts- IEC 60601-1- EN/IEC 60601-1-2 (2001)- IEC 60601-2-37
A2:2010/(R)2012A2:2010/(R)2012
- IEC 60601-1-2: 2014- IEC 60601-1-2: 2007
- IEC 60601-1-6:2013- IEC 60601-1-6:2013
- IEC 60601-2-37:2007- IEC 60601-2-37:2007
- ISO 14971:2007- ISO 14971:2007
- IEC 62366:2014- IEC 62366:2014

{16}------------------------------------------------

VII. PERFORMANCE DATA

The following performance data were provided to support substantial equivalence determination.

Biocompatibility testing

The patient contact components for A-scan, B-scan and UBM probes along with LIGHTMED Ultrasound System were subjected to cytotoxicity, sensitization, and irritation testing in accordance with FDA guidance- Use of International Standard ISO 10993-1, Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process. The patient contact materials for A-scan and UBM probes are surface contact device with mucosal membrane. Contact duration is limited to less than 30 minutes. (which is shorten than 24 hours mentioned in ISO 10993 A-limited.) The Biocompatibility testing results showed patient contact materials of LIGHTMED Ultrasound System conform to ISO 10993-1, 10993-5, ISO 10993-10, and ISO 10993-11.

Electrical safety and electromagnetic compatibility (EMC)

Electrical safety and EMC testing were conducted on LIGHTMED Ultrasound System, according to applicable federal and international safety and performance standards:

    • AAMI / ANSI ES60601-1:2005/(R)2012 And A1:2012, C1:2009/(R)2012 And A2:2010/(R)2012 (Consolidated Text)
    • IEC 60601-1-2:2014
    • IEC 60601-1-6:2013
    • IEC 60601-2-37:2007
    • ISO 14971:2007
    • IEC 62366:2014

The testing results demonstrate that LIGHTMED Ultrasound System comply with all the

{17}------------------------------------------------

required standards.

Software verification and validation testing

The software for LIGHTMED Ultrasound System was considered as a Moderate Level of Concern, since failures or latent flaws in the software could directly result in non-serious injury to the patient, operator, and/or bystander. Software verification and validation were performed, keep as recommended by FDA "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices".

Measurement accuracy

LIGHTMED Ultrasound System has been validated and is safe and effective for the intended use described in the indications for use.

VII. CONCLUSIONS

The LIGHTMED Ultrasound System is substantially equivalent to the predicate devices in technical characteristics, design features, operating principles, functional and performance characteristics, and for the intended uses in the stated medical specialties. The LIGHTMED Ultrasound System is designed to comply with applicable federal and international safety and performance standards. There are no new safety and effectiveness issues being raised.

§ 892.1560 Ultrasonic pulsed echo imaging system.

(a)
Identification. An ultrasonic pulsed echo imaging system is a device intended to project a pulsed sound beam into body tissue to determine the depth or location of the tissue interfaces and to measure the duration of an acoustic pulse from the transmitter to the tissue interface and back to the receiver. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II (special controls). A biopsy needle guide kit intended for use with an ultrasonic pulsed echo imaging system only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.